胸腺肽和转移因子联合尼美舒利治疗非特异性肋软骨炎疼痛的疗效观察  

Curative effect of combination of thymosin,.transfer factor and nimesulide on nonspecific costochondritis

作　　者：朱政和 

机构地区：[1]南海区人民医院外科,广东佛山528200

出　　处：《岭南现代临床外科》2016年第5期611-612,621,共3页Lingnan Modern Clinics in Surgery

基　　金：广东省佛山科技局2010年度科技立项(201008152)

摘　　要：目的探索胸腺肽、转移因子联合尼美舒利治疗非特异性肋软骨炎的疗效。方法选择2010年1月-2012年6月于我院外科门诊就诊的134例肋软骨炎患者作为研究对象,分尼美舒利单药治疗组（n=67）和胸腺肽、转移因子联合尼美舒利治疗的联合治疗组（n=67）,比较两组患者的疗效。结果联合用药组非特异性肋软骨炎的总体有效率95.5%（64/67）,尼美舒利单药治疗组为53.7%（36/67）,两组治疗效果差异有统计学意义。结论胸腺肽和转移因子联合尼美舒利治疗非特异性肋软骨炎的疗效优于单药尼美舒利。Objective To explore the effect of combining thymosin, transfer factor with nimesulide on treatment of nonspecific costochondritis. Methods 134 patients with costochondritis between January 2010 and June 2012 were included in the cohort and were assigned to nimesulide group （n=67） and observation group treated by combination of thymosin, transfer factor and nimesulide. The curative effect was compared between the two groups. Results The overall efficiency rates were 95.5% （64/67） and 53.7%（36/67） in observation group and nimesulide group respectively, and there was the statistical significant difference between the two groups. Conclusion The combination approach of thymosin, transfer factor and nimesulide showed better efficiency than single nimesulide alone in treatment of nonspecific costochondritis.

关 键 词：非特异性肋软骨炎 尼美舒利 胸腺肽 转移因子 

分 类 号：R681.3[医药卫生—骨科学]